Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry

Background: The genome-wide CRISPR-cas9 dropout screening has emerged as an outstanding approach for characterization of driver genes of tumor growth. The present study aims to investigate core genes related to clear cell renal cell carcinoma (ccRCC) cell viability by analyzing the CRISPR-cas9 scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Lai, Li, You, Zhijie, Cheng, Hui, Guo, Guodong, Tang, Chenchen, Xu, Luyun, Liu, Hongxia, Zhong, Wenting, Lin, Youyu, Wang, Qingshui, Lin, Yao, Wei, Yongbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861443/
https://www.ncbi.nlm.nih.gov/pubmed/35211510
http://dx.doi.org/10.3389/fmolb.2022.813428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861443/
https://www.ncbi.nlm.nih.gov/pubmed/35211510
http://dx.doi.org/10.3389/fmolb.2022.813428

Ejemplares similares